Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
hydroresearchpeptides.com
Hydro Research Peptides holds a Disclosed Labs trust grade of C (77/100), computed independently from 78 lab Certificates of Analysis (as of June 2026). That's a solid, verifiable track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is Hydro Research Peptides's trust score?
Hydro Research Peptides scores 77/100 (Grade C) on Disclosed Labs, from 78 lab COAs (as of June 2026).
How is Hydro Research Peptides's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: June 30, 2026 · 100% pass rate
Composite score based on 78 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 78 COAs attributed to this vendor. Last recomputed 2026-06-30.
Hydro Research is a dedicated scientific partner committed to elevating the standards of discovery by providing the highest-quality research peptides and chemicals. Our mission is to empower researchers through innovation and exceptional service, ensuring you have the precise tools needed to achieve groundbreaking results. We go beyond being a mere supplier, acting as a true research partner invested in the success of your scientific journey.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | BPC-157 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYDROK7Q3M2P · Report 92079 |
| Dec 8, 2025 | Tesamorelin | HPLC purity | PASS | 99.242% | Janoshik Analytical | Lot HYDROXA9KS7Z · Report 92025 |
| Dec 8, 2025 | BPC-157 | Identity & safety panels | PASS | -- | Janoshik Analytical |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="hydro-research"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/hydroresearchpeptides.com" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> ✓ Verified by Disclosed Labs — independent COA trust score </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Hydro Research Peptides's live profile at https://www.disclosedlabs.com/vendors/hydroresearchpeptides.com.
Links back to Hydro Research Peptides's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| AOD-9604 | vial | 5mg | $40.00$55.00 | $8.00 | In stock | 2026-07-08 | View → |
| BPC-157 | vial | 5mg | $36.00$51.00 | $7.20 | In stock | 2026-07-08 | View → |
| CJC-1295 | vial | 5mg | $30.00$40.00 | $6.00 | In stock | 2026-07-08 | View → |
| DSIP | vial | 5mg | $45.00$55.00 | $9.00 | In stock | 2026-07-08 | View → |
| Epitalon | vial | 10mg | $45.00$55.00 | $4.50 | In stock | 2026-07-08 | View → |
| GHK | vial | 100mg | $55.00 | $0.55 | In stock | 2026-07-08 | View → |
| GHK-Cu | vial | 5mg | $45.00$60.00 | $9.00 | In stock | 2026-07-08 | View → |
| Glutathione | vial | 1500mg | $95.00$159.00 | $0.06 | Sold out | 2026-07-08 | View → |
| Ipamorelin | vial | 5mg | $30.00$40.00 | $6.00 | In stock | 2026-07-08 | View → |
| KPV | vial | 10mg | $55.00$99.00 | $5.50 | In stock | 2026-07-08 | View → |
| Mazdutide | vial | 6mg | $90.00 | $15.00 | In stock | 2026-07-08 | View → |
| Mazdutide | vial | 60mg | $810.00 | $13.50 | In stock | 2026-07-08 | View → |
| MOTS-c | vial | 5mg | $35.00$39.00 | $7.00 | In stock | 2026-07-08 | View → |
| NAD+ | vial | 500mg | $50.00$60.00 | $0.10 | In stock | 2026-07-08 | View → |
| NAD+ | vial | 1000mg | $99.00 | $0.10 | In stock | 2026-07-08 | View → |
| PT-141 | vial | 10mg | $50.00$65.00 | $5.00 | In stock | 2026-07-08 | View → |
| Selank | vial | 5mg | $35.00 | $7.00 | In stock | 2026-07-08 | View → |
| SNAP-8 | vial | 20mg | $60.00 | $3.00 | In stock | 2026-07-08 | View → |
| SNAP-8 | vial | 200mg | $540.00 | $2.70 | In stock | 2026-07-08 | View → |
| SS-31 | vial | 50mg | $175.00$200.00 | $3.50 | In stock | 2026-07-08 | View → |
| Survodutide | vial | 6mg | $80.00 | $13.33 | In stock | 2026-07-08 | View → |
| Survodutide | vial | 60mg | $720.00 | $12.00 | In stock | 2026-07-08 | View → |
| TB-500 | vial | 10mg | $65.00$80.00 | $6.50 | In stock | 2026-07-08 | View → |
| Tesamorelin | vial | 10mg | $55.00$99.00 | $5.50 | In stock | 2026-07-08 | View → |
| Tesofensine | vial | 0.1mg | $60.00 | $600.00 | In stock | 2026-07-08 | View → |
Prices are scraped from hydroresearchpeptides.comand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
No physical address (-0.03), Clean presence (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot OPTIMA457SNF · Report 92587 |
| Dec 5, 2025 | Tirzepatide | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYDROV4N8C1Z · Report 89399 |
| Nov 21, 2025 | 5-Amino-1 MQ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYDROB7SHKSU · Report 89386 |
| Nov 20, 2025 | BPC-157 | HPLC purity | PASS | 99.068% | Janoshik Analytical | Lot HYDRO9B4C1MC · Report 89383 |
| Nov 20, 2025 | Thymosin Alpha-1 | HPLC purity | PASS | 99.164% | Janoshik Analytical | Lot HYDR06S1HTG1 · Report 89388 |
| Nov 20, 2025 | Melanotan 1 | HPLC purity | PASS | 99.597% | Janoshik Analytical | Lot HYDROCP7QHN3 · Report 89389 |
| Nov 20, 2025 | BPC-157 | HPLC purity | PASS | 99.598% | Janoshik Analytical | Lot HYDRO Q5L7R8S · Report 89382 |
| Nov 20, 2025 | Selank | HPLC purity | PASS | 99.037% | Janoshik Analytical | Lot HYDROH2P9X6D · Report 89392 |
| Nov 20, 2025 | KPV | HPLC purity | PASS | 99.746% | Janoshik Analytical | Lot HYDROBZ3UK38 · Report 89387 |
| Nov 20, 2025 | L-Glutathione | HPLC purity | PASS | 99.208% | Janoshik Analytical | Lot HYDROJ9Y2WD6 · Report 89395 |
| Nov 20, 2025 | KLOW 80 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYDRO48KA5F1 · Report 89391 |
| Nov 20, 2025 | Melanotan II | HPLC purity | PASS | 99.455% | Janoshik Analytical | Lot HYDRO11WN68L · Report 89390 |
| Nov 20, 2025 | GHK-Cu | HPLC purity | PASS | 99.657% | Janoshik Analytical | Lot HYDROD7PH63M · Report 89396 |
| Nov 20, 2025 | TB-500 | HPLC purity | PASS | 99.349% | Janoshik Analytical | Lot HYDRO3L6MDGQ · Report 89384 |
| Sep 2, 2025 | IGF-1 (Insulin-like Growth Factor 1) | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYD-IGFLR3-2508-02 · Report 75027 |
| Sep 2, 2025 | CJC/IPA | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HYD-CJCIPA-2508-01 · Report 75023 |
| Aug 15, 2025 | IGF-1 LR3 | HPLC purity | PASS | 99.523% | Janoshik Analytical | Lot HYD-IGFLR3-2508-02 · Report 75022 |
| Aug 13, 2025 | T15 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T15-K1X30 · Report 72906 |
| Aug 13, 2025 | R20 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R20-72975 · Report 72914 |
| Aug 13, 2025 | R40 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R40-MN0724 · Report 72918 |
| Aug 13, 2025 | T30 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T30-RXJ0725 · Report 72902 |
| Aug 5, 2025 | T15 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T15-K1X30 · Report 72905 |
| Aug 5, 2025 | R20 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R20-72975 · Report 72913 |
| Aug 5, 2025 | T30 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T30-RXJ0725 · Report 72901 |
| Aug 5, 2025 | R40 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R40-MN0724 · Report 72917 |
| Jul 30, 2025 | R20 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R20-72975 · Report 72915 |
| Jul 30, 2025 | Tirzepatide | HPLC purity | PASS | 99.908% | Janoshik Analytical | Lot HY-T60-0801B · Report 72908 |
| Jul 30, 2025 | Tirzepatide | HPLC purity | PASS | 99.867% | Janoshik Analytical | Lot HY-T15-K1X30 · Report 72904 |
| Jul 30, 2025 | T15 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T15-K1X30 · Report 72907 |
| Jul 30, 2025 | R40 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-R40-MN0724 · Report 72919 |
| Jul 30, 2025 | T60 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot HY-T60-0801B · Report 72911 |
| Jul 30, 2025 | Retatrutide | HPLC purity | PASS | 99.834% | Janoshik Analytical | Lot HY-R40-MN0724 · Report 72916 |
| Jul 30, 2025 | Tirzepatide | HPLC purity | PASS | 99.903% | Janoshik Analytical | Lot HY-T30-RXJ0725 · Report 72900 |
| Jul 30, 2025 | T30 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot AD-T30-29JUL5 · Report 72903 |
| Jul 15, 2025 | Tirzepatide | HPLC purity | PASS | 99.695% | Janoshik Analytical | Lot HRP-TZP-K94VMQ · Report 71331 |
| Jun 20, 2025 | KLOW | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot KLOW · Report 68649 |
| May 12, 2025 | Cagri/Reta Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot crb-H90X · Report 63605 |
| May 12, 2025 | NAD+ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot ND-R94KX2 · Report 63606 |
| Apr 28, 2025 | Epithalon | HPLC purity | PASS | 99.6% | Janoshik Analytical | Lot EP-YT34L1 · Report 63443 |
| Apr 28, 2025 | DSIP | HPLC purity | PASS | 99.865% | Janoshik Analytical | Lot DS-Z29TRQ · Report 63444 |
| Apr 28, 2025 | Retatrutide | HPLC purity | PASS | 99.288% | Janoshik Analytical | Lot reta10-H22W · Report 63445 |
| Apr 2, 2025 | GLOW (TB500 + BPC157 + GHK-CU) | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot glow-H21B · Report 61390 |
| Mar 18, 2025 | Semaglutide | HPLC purity | PASS | 99.15% | Janoshik Analytical | Lot SEM5-002 · Report 60153 |
| Mar 18, 2025 | Retatrutide | HPLC purity | PASS | 99.775% | Janoshik Analytical | Lot RET15-002 · Report 60171 |
| Mar 18, 2025 | Semaglutide | HPLC purity | PASS | 99.807% | Janoshik Analytical | Lot SEM10-002 · Report 60160 |
| Oct 11, 2024 | Retatrutide | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot RET15-003 · Report 50189 |
| Oct 4, 2024 | PT-141 | HPLC purity | PASS | 99.928% | Janoshik Analytical | Lot PT141-003 · Report 50063 |
| Oct 4, 2024 | SS-31 | HPLC purity | PASS | 99.922% | Janoshik Analytical | Lot SS31-003 · Report 50064 |
Disclosed Labs